FDA approval for Allergan's intraocular lens:
This article was originally published in Clinica
The FDA has given Allergan the go-ahead to market its Sensar foldable acrylic posterior chamber intraocular lens (IOL) in the US. The product is a next-generation acrylic IOL designed to minimise some of the unwanted side effect associated with current acrylic lenses, said the Irvine, California-based company. The new IOL is delivered into the eye using the company's implantation system called The Unfolder.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.